Literature DB >> 23060554

Fluorescent proteins enhance UVC PDT of cancer cells.

Masashi Momiyama1, Atsushi Suetsugu, Hiroaki Kimura, Hiroyuki Kishimoto, Ryoichi Aki, Akimitsu Yamada, Harumi Sakurada, Takashi Chishima, Michael Bouvet, Natalia N Bulgakova, Itaru Endo, Robert M Hoffman.   

Abstract

Cancer cells, with and without fluorescent protein expression, were irradiated with various doses of UVC (100, 400, and 600 J/m(2)). Dual-color Lewis lung carcinoma cells (LLC) and U87 human glioma cells, expressing GFP in the nucleus and RFP in the cytoplasm and non-colored LLC and U87 cells were cultured in 96-well plates. Eight hours after seeding, the cells were irradiated with the various doses of UVC. The resulting cell number was determined after 24 hours. Compared to non-colored LLC cells, the number of dual-color LLC cells decreased significantly due to UVC irradiation with 100 J/m(2) (p=0.003). Although there was no significant difference in the number of dual-color and non-colored U87 cells after 100 J/m(2) UVC irradiation (p=0.852), the number of dual-color U87 cells decreased significantly with respect to non-colored cells due to UVC irradiation with 400 J/m(2) and 600 J/m(2) (p=0.011 and p=0.009, respectively). Thus, both dual-color LLC and dual-color U87 cells were more sensitive to UVC light than non-colored LLC and U87 cells. These results suggest that the expression of fluorescent proteins in cancer cells can enhance photodynamic therapy (PDT) using UVC and possibly with other wavelengths of light as well.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23060554

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  13 in total

1.  The effect of photoimmunotherapy followed by liposomal daunorubicin in a mixed tumor model: a demonstration of the super-enhanced permeability and retention effect after photoimmunotherapy.

Authors:  Kohei Sano; Takahito Nakajima; Peter L Choyke; Hisataka Kobayashi
Journal:  Mol Cancer Ther       Date:  2013-12-19       Impact factor: 6.261

2.  Molecularly Targeted Cancer Combination Therapy with Near-Infrared Photoimmunotherapy and Near-Infrared Photorelease with Duocarmycin-Antibody Conjugate.

Authors:  Tadanobu Nagaya; Alexander P Gorka; Roger R Nani; Shuhei Okuyama; Fusa Ogata; Yasuhiro Maruoka; Peter L Choyke; Martin J Schnermann; Hisataka Kobayashi
Journal:  Mol Cancer Ther       Date:  2017-12-13       Impact factor: 6.261

3.  Eradication of melanoma in vitro and in vivo via targeting with a Killer-Red-containing telomerase-dependent adenovirus.

Authors:  Kiyoto Takehara; Shuya Yano; Hiroshi Tazawa; Hiroyuki Kishimoto; Nobuhiro Narii; Hiroyuki Mizuguchi; Yasuo Urata; Shunsuke Kagawa; Toshiyoshi Fujiwara; Robert M Hoffman
Journal:  Cell Cycle       Date:  2017-01-05       Impact factor: 4.534

4.  Near Infrared Photoimmunotherapy Targeting EGFR Positive Triple Negative Breast Cancer: Optimizing the Conjugate-Light Regimen.

Authors:  Tadanobu Nagaya; Kazuhide Sato; Toshiko Harada; Yuko Nakamura; Peter L Choyke; Hisataka Kobayashi
Journal:  PLoS One       Date:  2015-08-27       Impact factor: 3.240

5.  Towards PDT with Genetically Encoded Photosensitizer KillerRed: A Comparison of Continuous and Pulsed Laser Regimens in an Animal Tumor Model.

Authors:  Marina Shirmanova; Diana Yuzhakova; Ludmila Snopova; Gregory Perelman; Ekaterina Serebrovskaya; Konstantin Lukyanov; Ilya Turchin; Pavel Subochev; Sergey Lukyanov; Vladislav Kamensky; Elena Zagaynova
Journal:  PLoS One       Date:  2015-12-11       Impact factor: 3.240

6.  Fluorescence-guided surgery in combination with UVC irradiation cures metastatic human pancreatic cancer in orthotopic mouse models.

Authors:  Yukihiko Hiroshima; Ali Maawy; Yong Zhang; Sho Sato; Takashi Murakami; Mako Yamamoto; Fuminari Uehara; Shinji Miwa; Shuya Yano; Masashi Momiyama; Takashi Chishima; Kuniya Tanaka; Michael Bouvet; Itaru Endo; Robert M Hoffman
Journal:  PLoS One       Date:  2014-06-12       Impact factor: 3.240

7.  Combination photoimmunotherapy with monoclonal antibodies recognizing different epitopes of human epidermal growth factor receptor 2: an assessment of phototherapeutic effect based on fluorescence molecular imaging.

Authors:  Kimihiro Ito; Makoto Mitsunaga; Takashi Nishimura; Hisataka Kobayashi; Hisao Tajiri
Journal:  Oncotarget       Date:  2016-03-22

8.  Dynamic changes in the cell membrane on three dimensional low coherent quantitative phase microscopy (3D LC-QPM) after treatment with the near infrared photoimmunotherapy.

Authors:  Fusa Ogata; Tadanobu Nagaya; Shuhei Okuyama; Yasuhiro Maruoka; Peter L Choyke; Toyohiko Yamauchi; Hisataka Kobayashi
Journal:  Oncotarget       Date:  2017-11-01

9.  Improving the efficacy of Photoimmunotherapy (PIT) using a cocktail of antibody conjugates in a multiple antigen tumor model.

Authors:  Takahito Nakajima; Kohei Sano; Peter L Choyke; Hisataka Kobayashi
Journal:  Theranostics       Date:  2013-04-23       Impact factor: 11.556

10.  The effects of conjugate and light dose on photo-immunotherapy induced cytotoxicity.

Authors:  Takahito Nakajima; Kazuhide Sato; Hirofumi Hanaoka; Rira Watanabe; Toshiko Harada; Peter L Choyke; Hisataka Kobayashi
Journal:  BMC Cancer       Date:  2014-05-30       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.